Matthew P Deek

10PUBLICATIONS
122CO-AUTHORS
Decision makingPredictive and prognostic markersRadiation therapyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 08, 2026
Multi-institutional Patient-level Comparison of Decipher Genomic Classifier and Artera Multimodal Artificial Intelligence (MMAI) in Prostate Cancer.

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Jul 18, 2024
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer.

Philip Sutera, Jongmyung Kim, Ritesh Kumar

|Feb 23, 2023
Waiting for Big Changes in Limited-Stage Small-Cell Lung Cancer: For Now, More of the Same.

Matthew P Deek, Missak Haigentz, Salma K Jabbour

|Nov 11, 2022
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.

Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai

Pageof 2